MUMBAI, India, Nov. 7 -- Intellectual Property India has published a patent application (202441035076 A) filed by Biophore India Pharmaceuticals Pvt. Ltd., Hyderabad, Telangana, on May 3, 2024, for 'solid dispersions of 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-(4-{7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1- b][1,3]benzothiazol-2-yl}phenyl)urea dihydrochloride.'

Inventor(s) include Manik Reddy Pullagurla; Bhaskar Reddy Pitta; and Jagadeesh Babu Rangisetty.

The application for the patent was published on Nov. 7, under issue no. 45/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a solid dispersion of 1-(5-tert-butyl-1,2-oxazol-3- yl)-3-(4-{7-[2-(morpholin-4-yl) ethoxy]imidazo[2,1-b][1,3]...